Supplementary materials: Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver

These are peer-reviewed supplementary materials for the article 'Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver' published in the Journal of Comparative Effectiveness Research.

• Supplementary figure A: Median overall survival in the whole cohort according to the treatment modality after propensity score matching.
• Supplementary figure B: Overall survival according to the treatment modality after excluding patients with 90-day mortality of most definitive primary site surgery after propensity score matching.
• Supplementary figure C: Median overall survival comparison between single agent and multiagent chemotherapy after propensity score matching.
• Supplementary figure D: Median overall survival comparison between adjuvant and neoadjuvant chemotherapy after propensity score matching.
• Supplementary figure E: Median overall survival according to the treatment modality in (A) MSI-H and (B) MSI-L.
• Supplementary figure F: Median overall survival comparison between single agent and multiagent chemotherapy in (A) MSI-H and (B) MSI-L.
• Supplementary figure G: Median overall survival comparison between adjuvant and neoadjuvant chemotherapy in (A) MSI-H and (B) MSI-L.
• Supplementary Table A: Baseline characteristics of metastatic CRC patients with liver metastases according to the treatment modality after propensity score matching.
• Supplementary Table B: Baseline characteristics of metastatic CRC patients with liver metastases excluding patients with 90-day mortality of most definitive primary site surgery according to the treatment modality after propensity score matching.